Biomimetic Therapeutics, INC.
SEC CIK 1138400 · bmti · last insider filing 2013-03-18
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Watson Douglas G | Director | filed 2006 - 2013 |
| Christensen Thorkil K. | Director | filed 2009 - 2013 |
| Federico Charles | Director | filed 2007 - 2013 |
| Papasan Larry W | Director | filed 2006 - 2013 |
| Murphy James G | Director | filed 2006 - 2013 |
| Ehrlich Christopher B | Director | filed 2006 - 2013 |
| Lynch Samuel Eugene | Director · President and CEO | filed 2006 - 2013 |
| Friedlaender Gary E | Director | filed 2006 - 2013 |
| Dyrberg Thomas | Director | filed 2006 - 2007 |
| Hanham ANN | Director | filed 2006 - 2006 |
| Caplan Arnold I | Director | filed 2006 - 2006 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Bullock Lawrence E | Chief Financial Officer | filed 2006 - 2013 |
| Pagano Russell P. | VP, Reg. & Clinical Affairs | filed 2008 - 2013 |
| Douglas Earl Martin | General Counsel | filed 2006 - 2012 |
| Hirsch Steven Neal | COO & Executive VP | filed 2006 - 2010 |
| Hart Charles Edward | Chief Scientific Officer &VP | filed 2006 - 2008 |
| Monsor James A. | VP - Operations | filed 2007 - 2008 |
| Citron Mark Barry | Sr. Vice President | filed 2006 - 2007 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.